IT
About
Illimis Therapeutics is a biotechnology company focused on translating cutting-edge science into innovative medicines for intractable diseases. Their core efforts include developing treatments for Alzheimer's disease, such as their GAIA-Aβ program aimed at overcoming limitations of existing therapies by addressing ARIA. They serve patients and their families suffering from debilitating conditions by striving to improve their quality of life through sustainable innovation.
Technology stack
detected 2026-06-12Est. monthly stack spend~$180/mo
Email
Microsoft 365
Hosting
self_managed
Stack
jQuery
Analytics
Google Analytics 4
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Illimis Therapeutics do?
Illimis Therapeutics is a biotechnology company focused on translating cutting-edge science into innovative medicines for intractable diseases. Their core efforts include developing treatments for Alzheimer's disease, such as their GAIA-Aβ program aimed at overcoming limitations of existing therapies by addressing ARIA. They serve patients and their families suffering from debilitating conditions by striving to improve their quality of life through sustainable innovation.
Where is Illimis Therapeutics headquartered?
Illimis Therapeutics is headquartered in Seoul, South Korea.
When was Illimis Therapeutics founded?
Illimis Therapeutics was founded in 2021.